Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Catherine Belle Meador, M.D.

Concepts (122)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms202024133811.230 Why?
Drug Resistance, Neoplasm11202453050.930 Why?
Small Cell Lung Carcinoma720244230.900 Why?
Thoracic Neoplasms120232670.710 Why?
Carcinoma, Non-Small-Cell Lung5202353140.690 Why?
Leadership2201613850.540 Why?
Molecular Targeted Therapy3202028110.490 Why?
Genotype32021129900.490 Why?
Protein Kinase Inhibitors6202156720.490 Why?
Antineoplastic Agents62021136420.450 Why?
Mutation122024300530.360 Why?
Biomedical Research2201634290.350 Why?
MAP Kinase Signaling System2201514860.320 Why?
Proto-Oncogene Proteins B-raf2201520570.300 Why?
Acrylamides320172600.240 Why?
Neoplasms42023221730.240 Why?
Negotiating220161500.240 Why?
Education, Medical, Graduate1201623730.230 Why?
Education, Medical1201617250.230 Why?
Exodeoxyribonucleases120241920.210 Why?
Epigenomics220249430.190 Why?
Aniline Compounds3201710690.190 Why?
Career Choice220167560.170 Why?
Gene Amplification1202410890.170 Why?
Biology120212900.170 Why?
Paraneoplastic Syndromes, Nervous System12019240.170 Why?
Tumor Microenvironment3202438780.160 Why?
Genetic Variation1201465670.160 Why?
Quinazolines2201513710.150 Why?
Cardiology Service, Hospital120192390.150 Why?
Mice, Nude4201736140.140 Why?
Focal Adhesion Protein-Tyrosine Kinases120171860.140 Why?
Receptor, EphA212016410.130 Why?
Phosphoproteins1202424480.120 Why?
Exons1202123910.120 Why?
Colorectal Neoplasms1201569380.120 Why?
src-Family Kinases120175350.120 Why?
Group Processes120162280.120 Why?
Humans2620247615960.110 Why?
Cell Line, Tumor72024169900.110 Why?
Niacinamide120164130.110 Why?
Lymphocytes, Tumor-Infiltrating1201910920.110 Why?
Professional Competence120164310.100 Why?
Curriculum2201637430.100 Why?
INDEL Mutation120132660.100 Why?
Patient Admission1201913670.100 Why?
Cell Lineage1202025570.090 Why?
Cell Transformation, Neoplastic2202428270.090 Why?
Benzamides1201613710.090 Why?
DNA, Neoplasm1201517450.090 Why?
Xenograft Model Antitumor Assays3202436050.080 Why?
Animals1120241684750.080 Why?
Academic Medical Centers1201927590.080 Why?
Antineoplastic Combined Chemotherapy Protocols32017117420.070 Why?
Piperazines1201725230.070 Why?
Receptor Protein-Tyrosine Kinases1201416260.070 Why?
Protein-Tyrosine Kinases1201524250.070 Why?
Sensitivity and Specificity12021146650.060 Why?
Genome, Human2201544250.060 Why?
Octamer Transcription Factors12023180.060 Why?
Healthcare Disparities1201933580.060 Why?
Mice82024815390.050 Why?
Biopsy1201567660.050 Why?
Lactates120234050.050 Why?
Cell Proliferation22016104510.050 Why?
Neoplasm Recurrence, Local2201792800.050 Why?
Health Services Accessibility1201954400.050 Why?
Genetic Testing1201435370.050 Why?
Chemokines120249590.040 Why?
Proto-Oncogene Proteins c-myc120249880.040 Why?
Treatment Outcome32020646850.040 Why?
Genomics1201458210.040 Why?
Adenocarcinoma1201563450.040 Why?
Gene Expression Regulation, Neoplastic2202485540.040 Why?
Basic Helix-Loop-Helix Transcription Factors1202311360.040 Why?
Pneumonectomy1202311190.030 Why?
Heart Failure12019116710.030 Why?
Melanoma1201457090.030 Why?
Chemotherapy, Adjuvant1202335140.030 Why?
Survival Rate22019127230.030 Why?
Drug Screening Assays, Antitumor120157180.030 Why?
Immunity, Innate1202430660.020 Why?
Aged420191693100.020 Why?
Drug Synergism1201617570.020 Why?
Combined Modality Therapy1202385270.020 Why?
Epigenesis, Genetic1202438010.020 Why?
CD8-Positive T-Lymphocytes1202445800.020 Why?
Drug Evaluation, Preclinical1201513340.020 Why?
DNA Methylation1202443990.020 Why?
Benzimidazoles120158580.020 Why?
ras Proteins1201510540.020 Why?
Male520243608460.020 Why?
Transfection1201757740.020 Why?
Signal Transduction32017234470.020 Why?
Neoplasm Staging12023111200.020 Why?
Macrophages1202357670.020 Why?
Immunotherapy1202446520.020 Why?
Inpatients1201925480.020 Why?
Health Status Disparities1201918530.020 Why?
Retrospective Studies32023806470.020 Why?
Proto-Oncogene Proteins p21(ras)1201517450.020 Why?
Boston1201993270.020 Why?
Patient Readmission1201932710.020 Why?
Drug Therapy, Combination1201563120.020 Why?
Lung12023100020.010 Why?
DNA Copy Number Variations1201320200.010 Why?
Female520243927050.010 Why?
Transcription Factors12023121300.010 Why?
Aged, 80 and over22019589840.010 Why?
Sequence Analysis, DNA1201347400.010 Why?
Longitudinal Studies12017146080.010 Why?
High-Throughput Nucleotide Sequencing1201336390.010 Why?
Middle Aged320192209210.010 Why?
Apoptosis1201694900.010 Why?
Prognosis12019296290.010 Why?
Risk Assessment12019239960.010 Why?
Time Factors12019399690.010 Why?
Follow-Up Studies12017391060.010 Why?
Polymorphism, Single Nucleotide12013159360.010 Why?
Prospective Studies12017544230.010 Why?
Risk Factors12019742130.010 Why?
Adult120172212100.000 Why?
Meador's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (122)
Explore
_
Co-Authors (111)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.